{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:13:38Z","timestamp":1769973218665,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2017.79","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T13:42:21Z","timestamp":1493127741000},"page":"e1104-e1104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Naltrexone modulates dopamine release following chronic, but not acute amphetamine administration: a translational study"],"prefix":"10.1038","volume":"7","author":[{"given":"N","family":"Jayaram-Lindstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Guterstam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"H\u00e4ggkvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Ericson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T","family":"Malml\u00f6f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Schilstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Halldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Cervenka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9362-1516","authenticated-orcid":false,"given":"T","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A-L","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Franck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"BFtp201779_CR1","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A . Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005; 75: 406\u2013433.","journal-title":"Prog Neurobiol"},{"key":"BFtp201779_CR2","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0006-3223(00)01038-6","volume":"49","author":"WC Drevets","year":"2001","unstructured":"Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry 2001; 49: 81\u201396.","journal-title":"Biol Psychiatry"},{"key":"BFtp201779_CR3","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.neubiorev.2003.08.013","volume":"27","author":"JM Swanson","year":"2003","unstructured":"Swanson JM, Volkow ND . Serum and brain concentrations of methylphenidate: implications for use and abuse. Neurosci Biobehav Rev 2003; 27: 615\u2013621.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFtp201779_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0893-133X(02)00366-4","volume":"27","author":"M Leyton","year":"2002","unstructured":"Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A . Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: a PET\/[11C]raclopride study in healthy men. Neuropsychopharmacology 2002; 27: 1027\u20131035.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201779_CR5","doi-asserted-by":"publisher","first-page":"E255","DOI":"10.1073\/pnas.1101920108","volume":"108","author":"KS Smith","year":"2011","unstructured":"Smith KS, Berridge KC, Aldridge JW . Disentangling pleasure from incentive salience and learning signals in brain reward circuitry. Proc Natl Acad Sci U S A 2011; 108: E255\u2013E264.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"BFtp201779_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/0006-3223(95)00110-7","volume":"39","author":"LH Brauer","year":"1996","unstructured":"Brauer LH, de Wit H . Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry 1996; 39: 26\u201332.","journal-title":"Biol Psychiatry"},{"key":"BFtp201779_CR7","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","volume":"24","author":"N Jayaram-Lindstr\u00f6m","year":"2004","unstructured":"Jayaram-Lindstr\u00f6m N, Wennberg P, Hurd YL, Franck J . Effects of naltrexone on the subjective response to amphetamine in healthy volunteers. J Clin Psychopharmacol 2004; 24: 665\u2013669.","journal-title":"J Clin Psychopharmacol"},{"key":"BFtp201779_CR8","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","volume":"33","author":"N Jayaram-Lindstr\u00f6m","year":"2008","unstructured":"Jayaram-Lindstr\u00f6m N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J . Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. Neuropsychopharmacology 2008; 33: 1856\u20131863.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201779_CR9","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s00213-014-3449-x","volume":"231","author":"KR Marks","year":"2014","unstructured":"Marks KR, Lile JA, Stoops WW, Rush CR . Separate and combined impact of acute naltrexone and alprazolam on subjective and physiological effects of oral d-amphetamine in stimulant users. Psychopharmacology (Berl) 2014; 231: 2741\u20132750.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201779_CR10","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/npp.2015.83","volume":"40","author":"LA Ray","year":"2015","unstructured":"Ray LA, Bujarski S, Courtney KE, Moallem NR, Lunny K, Roche D et al. The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a Double-Blind, Placebo-Controlled Laboratory Study. Neuropsychopharmacology 2015; 40: 2347\u20132356.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201779_CR11","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","volume":"165","author":"N Jayaram-Lindstr\u00f6m","year":"2008","unstructured":"Jayaram-Lindstr\u00f6m N, Hammarberg A, Beck O, Franck J . Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am J Psychiatry 2008; 165: 1442\u20131448.","journal-title":"Am J Psychiatry"},{"key":"BFtp201779_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.euroneuro.2010.06.018","volume":"20","author":"JE Grant","year":"2010","unstructured":"Grant JE, Odlaug BL, Kim SW . A double-blind, placebo-controlled study of N-acetyl cysteine plus naltrexone for methamphetamine dependence. Eur Neuropsychopharmacol 2010; 20: 823\u2013828.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp201779_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1176\/appi.ajp.2011.11071121","volume":"169","author":"J Tiihonen","year":"2012","unstructured":"Tiihonen J, Krupitsky E, Verbitskaya E, Blokhina E, Mamontova O, F\u00f6hr J et al. Naltrexone implant for the treatment of polydrug dependence: a randomized controlled trial. Am J Psychiatry 2012; 169: 531\u2013536.","journal-title":"Am J Psychiatry"},{"key":"BFtp201779_CR14","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1369-1600.2009.00150.x","volume":"14","author":"J H\u00e4ggkvist","year":"2009","unstructured":"H\u00e4ggkvist J, Lindholm S, Franck J . The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat. Addict Biol 2009; 14: 260\u2013269.","journal-title":"Addict Biol"},{"key":"BFtp201779_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbr.2008.08.021","volume":"197","author":"J H\u00e4ggkvist","year":"2009","unstructured":"H\u00e4ggkvist J, Lindholm S, Franck J . The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat. Behav Brain Res 2009 30; 197: 219\u2013224.","journal-title":"Behav Brain Res"},{"key":"BFtp201779_CR16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1369-1600.2009.00199.x","volume":"16","author":"J H\u00e4ggkvist","year":"2011","unstructured":"H\u00e4ggkvist J, Bj\u00f6rkholm C, Steensland P, Lindholm S, Franck J, Schilstr\u00f6m B . Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat. Addict Biol 2011; 16: 20\u201329.","journal-title":"Addict Biol"},{"key":"BFtp201779_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/syn.890160402","volume":"16","author":"ND Volkow","year":"1994","unstructured":"Volkow ND, Wang GJ, Fowler JS, Logan J, Schlyer D, Hitzemann R et al. Imaging endogenous dopamine competition with [11C]raclopride in the human brain. Synapse 1994; 16: 255\u2013262.","journal-title":"Synapse"},{"key":"BFtp201779_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/00004647-200003000-00001","volume":"20","author":"M Laruelle","year":"2000","unstructured":"Laruelle M . Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000; 20: 423\u2013451.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFtp201779_CR19","doi-asserted-by":"publisher","first-page":"3998","DOI":"10.1523\/JNEUROSCI.4370-06.2007","volume":"27","author":"I Boileau","year":"2007","unstructured":"Boileau I, Dagher A, Leyton M, Welfeld K, Booij L, Diksic M et al. Conditioned dopamine release in humans: a positron emission tomography [11C]raclopride study with amphetamine. J Neurosci 2007 11; 27: 3998\u20134003.","journal-title":"J Neurosci"},{"key":"BFtp201779_CR20","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.neuroimage.2007.12.063","volume":"40","author":"S Cervenka","year":"2008","unstructured":"Cervenka S, B\u00e4ckman L, Csel\u00e9nyi Z, Halldin C, Farde L . Associations between dopamine D2-receptor binding and cognitive performance indicate functional compartmentalization of the human striatum. NeuroImage 2008; 40: 1287\u20131295.","journal-title":"NeuroImage"},{"key":"BFtp201779_CR21","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang D-R, Huang Y et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003; 23: 285\u2013300.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFtp201779_CR22","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1097\/00004647-200109000-00002","volume":"21","author":"O Mawlawi","year":"2001","unstructured":"Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001; 21: 1034\u20131057.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFtp201779_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0306-4522(99)00575-8","volume":"96","author":"D Joel","year":"2000","unstructured":"Joel D, Weiner I . The connections of the dopaminergic system with the striatum in rats and primates: an analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 2000; 96: 451\u2013474.","journal-title":"Neuroscience"},{"issue":"3 Pt 1","key":"BFtp201779_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP . Simplified reference tissue model for PET receptor studies. NeuroImage 1996; 4 (3 Pt 1): 153\u2013158.","journal-title":"NeuroImage"},{"key":"BFtp201779_CR25","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"1998","unstructured":"Paxinos G, Watson C . The Rat Brain in Stereotaxic Coordinates. 4th edn, San Diego, CA, USA: Academic Press, 1998."},{"key":"BFtp201779_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-2999(94)00726-N","volume":"275","author":"CA Schad","year":"1995","unstructured":"Schad CA, Justice JB, Holtzman SG . Naloxone reduces the neurochemical and behavioral effects of amphetamine but not those of cocaine. Eur J Pharmacol 1995; 275: 9\u201316.","journal-title":"Eur J Pharmacol"},{"key":"BFtp201779_CR27","doi-asserted-by":"publisher","first-page":"RC184","DOI":"10.1523\/JNEUROSCI.21-23-j0002.2001","volume":"21","author":"MF Olive","year":"2001","unstructured":"Olive MF, Koenig HN, Nannini MA, Hodge CW . Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine. J Neurosci 2001; 21: RC184.","journal-title":"J Neurosci"},{"key":"BFtp201779_CR28","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/sj.npp.1301463","volume":"33","author":"Y Xia","year":"2008","unstructured":"Xia Y, He L, Whistler JL, Hjelmstad GO . Acute amphetamine exposure selectively desensitizes kappa-opioid receptors in the nucleus accumbens. Neuropsychopharmacology 2008; 33: 892\u2013900.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201779_CR29","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1124\/jpet.300.3.932","volume":"300","author":"CA Schad","year":"2002","unstructured":"Schad CA, Justice JB, Holtzman SG . Endogenous opioids in dopaminergic cell body regions modulate amphetamine-induced increases in extracellular dopamine levels in the terminal regions. J Pharmacol Exp Ther 2002; 300: 932\u2013938.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201779_CR30","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1017\/S1461145712000818","volume":"16","author":"J Guterstam","year":"2013","unstructured":"Guterstam J, Jayaram-Lindstr\u00f6m N, Cervenka S, Frost JJ, Farde L, Halldin C et al. Effects of amphetamine on the human brain opioid system\u2014a positron emission tomography study. Int J Neuropsychopharmacol 2013; 16: 763\u2013769.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp201779_CR31","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.biopsych.2012.01.027","volume":"72","author":"A Colasanti","year":"2012","unstructured":"Colasanti A, Searle GE, Long CJ, Hill SP, Reiley RR, Quelch D et al. Endogenous opioid release in the human brain reward system induced by acute amphetamine administration. Biol Psychiatry 2012; 72: 371\u2013377.","journal-title":"Biol Psychiatry"},{"key":"BFtp201779_CR32","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1017\/S1461145714000704","volume":"17","author":"I Mick","year":"2014","unstructured":"Mick I, Myers J, Stokes PRA, Erritzoe D, Colasanti A, Bowden-Jones H et al. Amphetamine induced endogenous opioid release in the human brain detected with [11C]carfentanil PET: replication in an independent cohort. Int J Neuropsychopharmacol 2014; 17: 2069\u20132074.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BFtp201779_CR33","first-page":"367","volume":"54","author":"J Turchan","year":"2002","unstructured":"Turchan J, Maj M, Przew\u0142ocka B, Przew\u0142ocki R . Effect of cocaine and amphetamine on biosynthesis of proenkephalin and prodynorphin in some regions of the rat limbic system. Pol J Pharmacol 2002; 54: 367\u2013372.","journal-title":"Pol J Pharmacol"},{"key":"BFtp201779_CR34","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/mp.2014.164","volume":"20","author":"M Peci\u00f1a","year":"2015","unstructured":"Peci\u00f1a M, Zubieta J-K . Molecular mechanisms of placebo responses in humans. Mol Psychiatry 2015; 20: 416\u2013423.","journal-title":"Mol Psychiatry"},{"key":"BFtp201779_CR35","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/BF02246020","volume":"125","author":"SH Mitchell","year":"1996","unstructured":"Mitchell SH, Laurent CL, de Wit H . Interaction of expectancy and the pharmacological effects of d-amphetamine: subjective effects and self-administration. Psychopharmacology (Berl) 1996; 125: 371\u2013378.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201779_CR36","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1038\/npp.2016.99","volume":"41","author":"KE Courtney","year":"2016","unstructured":"Courtney KE, Ghahremani DG, Ray LA . The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans. Neuropsychopharmacology 2016; 41: 2872\u20132881.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201779_CR37","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","volume":"26","author":"ND Volkow","year":"2006","unstructured":"Volkow ND, Wang G-J, Telang F, Fowler JS, Logan J, Childress A-R et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006; 26: 6583\u20136588.","journal-title":"J Neurosci"},{"key":"BFtp201779_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1523\/JNEUROSCI.4794-10.2011","volume":"31","author":"J Wiskerke","year":"2011","unstructured":"Wiskerke J, Schetters D, van Es IE, van Mourik Y, den Hollander BRO, Schoffelmeer ANM et al. \u03bc-Opioid receptors in the nucleus accumbens shell region mediate the effects of amphetamine on inhibitory control but not impulsive choice. J Neurosci 2011; 31: 262\u2013272.","journal-title":"J Neurosci"},{"key":"BFtp201779_CR39","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1001\/archpsyc.63.12.1386","volume":"63","author":"I Boileau","year":"2006","unstructured":"Boileau I, Dagher A, Leyton M, Gunn RN, Baker GB, Diksic M et al. Modeling sensitization to stimulants in humans: an [11C]raclopride\/positron emission tomography study in healthy men. Arch Gen Psychiatry 2006; 63: 1386\u20131395.","journal-title":"Arch Gen Psychiatry"},{"key":"BFtp201779_CR40","doi-asserted-by":"publisher","first-page":"7471","DOI":"10.1523\/JNEUROSCI.17-19-07471.1997","volume":"17","author":"MF Olive","year":"1997","unstructured":"Olive MF, Anton B, Micevych P, Evans CJ, Maidment NT . Presynaptic versus postsynaptic localization of mu and delta opioid receptors in dorsal and ventral striatopallidal pathways. J Neurosci 1997; 17: 7471\u20137479.","journal-title":"J Neurosci"},{"key":"BFtp201779_CR41","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.euroneuro.2004.11.004","volume":"15","author":"MAFM Gerrits","year":"2005","unstructured":"Gerrits MAFM, Kuzmin AV, van Ree JM . Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone. Eur Neuropsychopharmacol 2005; 15: 297\u2013303.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFtp201779_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/0006-8993(92)90912-S","volume":"584","author":"EM Unterwald","year":"1992","unstructured":"Unterwald EM, Horne-King J, Kreek MJ . Chronic cocaine alters brain mu opioid receptors. Brain Res 1992; 584: 314\u2013318.","journal-title":"Brain Res"},{"key":"BFtp201779_CR43","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1097\/00001756-199408150-00018","volume":"5","author":"EM Unterwald","year":"1994","unstructured":"Unterwald EM, Rubenfeld JM, Kreek MJ . Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors. Neuroreport 1994; 5: 1613\u20131616.","journal-title":"Neuroreport"},{"key":"BFtp201779_CR44","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/nm1196-1225","volume":"2","author":"JK Zubieta","year":"1996","unstructured":"Zubieta JK, Gorelick DA, Stauffer R, Ravert HT, Dannals RF, Frost JJ . Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat Med 1996; 2: 1225\u20131229.","journal-title":"Nat Med"},{"key":"BFtp201779_CR45","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.biopsych.2005.02.026","volume":"57","author":"DA Gorelick","year":"2005","unstructured":"Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino M et al. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry 2005; 57: 1573\u20131582.","journal-title":"Biol Psychiatry"},{"key":"BFtp201779_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00213-008-1225-5","volume":"200","author":"DA Gorelick","year":"2008","unstructured":"Gorelick DA, Kim YK, Bencherif B, Boyd SJ, Nelson R, Copersino ML et al. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology (Berl) 2008; 200: 475\u2013486.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtp201779_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.biopsych.2010.05.003","volume":"68","author":"UE Ghitza","year":"2010","unstructured":"Ghitza UE, Preston KL, Epstein DH, Kuwabara H, Endres CJ, Bencherif B et al. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry 2010; 68: 697\u2013703.","journal-title":"Biol Psychiatry"},{"key":"BFtp201779_CR48","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1038\/npp.2013.143","volume":"38","author":"SD Comer","year":"2013","unstructured":"Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA et al. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology 2013; 38: 2427\u20132438.","journal-title":"Neuropsychopharmacology"},{"key":"BFtp201779_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/10550490903077929","volume":"18","author":"JM Schmitz","year":"2009","unstructured":"Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Moeller FG . High-dose naltrexone therapy for cocaine-alcohol dependence. Am J Addict 2009; 18: 356\u2013362.","journal-title":"Am J Addict"},{"key":"BFtp201779_CR50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1192\/bjp.bp.107.041228","volume":"193","author":"MRC Daglish","year":"2008","unstructured":"Daglish MRC, Williams TM, Wilson SJ, Taylor LG, Eap CB, Augsburger M et al. Brain dopamine response in human opioid addiction. Br J Psychiatry 2008; 193: 65\u201372.","journal-title":"Br J Psychiatry"},{"key":"BFtp201779_CR51","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/adb.12073","volume":"19","author":"BJ Watson","year":"2014","unstructured":"Watson BJ, Taylor LG, Reid AG, Wilson SJ, Stokes PR, Brooks DJ et al. Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET. Addict Biol 2014; 19: 1032\u20131040.","journal-title":"Addict Biol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp201779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201779","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/tp.2017.79","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/tp201779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:51:40Z","timestamp":1671727900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,4]]}},"alternative-id":["BFtp201779"],"URL":"https:\/\/doi.org\/10.1038\/tp.2017.79","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]},"assertion":[{"value":"28 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}